October 2026
October 2026 | Features
Unlocking Clinical Trial Enrollment with AI Screening
It’s not a patient population problem. It’s a signal-extraction problem.
Sunil Gupta, MD, and Joshua Koo, MS, BS
October 2026 | Medical Editors' Page
Caution: May Hallucinate When Prompted
Allen C. Ho, MD; Robert L. Avery, MD; and Lejla Vajzovic, MD
October 2026 | Features
AI Chatbots in the Retina Clinic
Large language models are not coming for your job. But they may redefine what your job looks like.
Fares Antaki, MDCM
October 2026 | Ocular Oncology
Winning the Battle for Life, Eye, and Vision
The field has evolved substantially to offer treatments for uveal melanoma beyond enucleation, but we still have far to go in preserving vision.
Antonio Bechara Ghobril, MD, FEBOophth, FMH; Salaam Botros, MBBS; and Carol L. Shields, MD
Popular Articles
September 2026 | Visually Speaking
A Patch With Potential
An amniotic membrane transplant was used to treat a patient with chronic, complex macular hole.
Osama M. Ahmed, MD, and Mohsin H. Ali, MD
September 2026 Insert
One to Watch: Alexis Warren, MD
Alexis Warren, MD
May/June 2026 Supplement | Coding Advisor
Using E/M and Eye Visit Codes When Surgical Reimbursement Declines
These strategies can help you determine which code to use.
Matthew Baugh, MHA, COT, OCS, OCSR
September 2026 | Oncology
Cancer-Associated Retinopathy With Thymic Carcinoma
A multimodal approach to treatment led to meaningful visual improvement despite poor prognostic signs on OCT.
Mena Kozman, MD; Aaron Shi, MD; Nyaari Kothiya; Sami Dahr, MD; and Rabia Karani, MD, MPH
September 2026 Supplement | Editorial
The Bright Side of AI
Alan Ruby, MD
Retina News
